ORITAVANCIN-FORMULIERUNGEN
European patent · EP3416672 · In force
Register entry
- Publication number
- EP3416672
- Application number
- EP17753910
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Feb 17, 2017
- Published
- Dec 26, 2018
- Granted
- Oct 23, 2024
- Protection ends at the latest
- Feb 16, 2037
- Next annual fee due
- Feb 28, 2027
- IPC classes
- A61K 38/14 (2006.01)A61K 47/40 (2006.01)A61P 31/04 (2006.01)
- Priority
- US 201662296989 P 18.02.2016
- PCT application
- PCT/US2017/018340 17.02.2017
- PCT publication
- WO2017/143169 24.08.2017
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 1, 2026
Change
Published in Swissreg on 01.03.2026
- Sep 3, 2025
Change
Published in Swissreg on 03.09.2025
- Mar 1, 2025
Change
Published in Swissreg on 01.03.2025
- Oct 26, 2024
Agent entered
- Representative
- VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 26.10.2024
- Oct 23, 2024
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 23.10.2024
Parties
Inventor
GRIFFITH, David, C.
Parsippany NJ 07054, US
FAR, Adel, Rafai
Parsippany NJ 07054, US
LEHOUX, Dario
Parsippany NJ 07054, US
KRISHNA, Gopal
Parsippany NJ 07054, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.